Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug interaction between propafenone and metoprolol.

F Wagner, D Kalusche, D Trenk

    British Journal of Clinical Pharmacology
    |August 1, 1987
    PubMed
    Summary

    Combining metoprolol and propafenone significantly increases metoprolol levels and its beta-adrenoceptor blocking activity. Healthcare providers should reduce metoprolol dosage when co-prescribing with propafenone to avoid adverse effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Basics for the Use of Andexanet].

    Hamostaseologie·2023
    Same author

    Energy enhancement of the target surface electron by using a 200 TW sub-picosecond laser.

    Optics letters·2018
    Same author

    The accuracy of image-based safety analysis for robotic cochlear implantation.

    International journal of computer assisted radiology and surgery·2018
    Same author

    Dual Ion Species Plasma Expansion from Isotopically Layered Cryogenic Targets.

    Physical review letters·2018
    Same author

    Using an orbit shield during volume perfusion CT: is it useful protection or an obstacle?

    Clinical radiology·2018
    Same author

    Another Important Pitfall in the Diagnosis of Dural Sinus Thrombosis in Neonates.

    AJNR. American journal of neuroradiology·2018

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine

    Background:

    • Metoprolol and propafenone are commonly prescribed cardiovascular drugs.
    • Understanding their pharmacokinetic and pharmacodynamic interactions is crucial for patient safety.

    Purpose of the Study:

    • To investigate the effects of combined metoprolol and propafenone treatment on steady-state plasma concentrations.
    • To evaluate the pharmacokinetic and beta-adrenoceptor blocking activity of metoprolol and propafenone, alone and in combination.

    Main Methods:

    • Assessed steady-state plasma concentrations in patients on monotherapy versus combination therapy.
    • Conducted single-dose pharmacokinetic studies in healthy volunteers.
    • Measured beta-adrenoceptor blocking activity via exercise-induced tachycardia.

    Related Experiment Videos

    Main Results:

    • Concomitant propafenone administration increased metoprolol steady-state levels 2-5 fold.
    • Oral clearance of metoprolol decreased approximately two-fold with propafenone co-administration.
    • Beta-adrenoceptor blocking activity of metoprolol was prolonged when combined with propafenone.
    • No significant changes in propafenone pharmacokinetics were observed.

    Conclusions:

    • Propafenone significantly impacts metoprolol pharmacokinetics and pharmacodynamics.
    • A dose reduction of metoprolol is recommended when co-administered with propafenone.
    • Adverse events, including nightmares and left ventricular failure, were noted in combination therapy.